Deep Track Capital, LP
- SEC CIK
- 0001856083
- Latest filing
- Aug 14, 2026
Holdings in Q1 2025
Holdings as of Mar 31, 2025, filed May 15, 2025. Long positions only; changes compare share counts with Q4 2024.
- Positions
- 69
- +8 vs. Q4 2024
- Portfolio value
- $3.09B
- +$420.9M (+15.8%) vs. Q4 2024
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ITCIIntra-Cellular Therapies, Inc. | COM | 2,000,000 | $263.8M | 8.5% | 00.0% | Unchanged | History |
| GHGuardant Health, Inc. | COM | 5,443,721 | $231.9M | 7.5% | −975,845−15.2% | Reduced | History |
| DVAXDynavax Technologies Corp | COM NEW | 17,791,486 | $230.8M | 7.5% | 00.0% | Unchanged | History |
| IMVTImmunovant, Inc. | COM | 9,500,000 | $162.4M | 5.3% | +3,500,000+58.3% | Added | History |
| PTGXProtagonist Therapeutics, Inc | COM | 3,000,000 | $145.1M | 4.7% | +2,000,000+200.0% | Added | History |
| IONSIonis Pharmaceuticals Inc | COM | 4,564,207 | $137.7M | 4.5% | +2,630,279+136.0% | Added | History |
| AKROAkero Therapeutics, Inc. | COM | 3,210,270 | $130.0M | 4.2% | +1,720,270+115.5% | Added | History |
| CYTKCytokinetics Inc | COM NEW | 3,073,853 | $123.5M | 4.0% | +573,853+23.0% | Added | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 5,000,000 | $109.3M | 3.5% | +725,079+17.0% | Added | History |
| OCULOcular Therapeutix, Inc | COM | 14,294,420 | $104.8M | 3.4% | +1,458,138+11.4% | Added | History |
| BBIOBridgeBio Pharma, Inc. | COM | 2,800,000 | $96.8M | 3.1% | +1,980,838+241.8% | Added | History |
| TARSTarsus Pharmaceuticals, Inc. | COM | 1,484,266 | $76.2M | 2.5% | +1,484,266 | New | History |
| VRDNViridian Therapeutics, Inc. | COM | 5,380,449 | $72.5M | 2.3% | +857,708+19.0% | Added | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 4,100,000 | $71.0M | 2.3% | +1,300,000+46.4% | Added | History |
| ETNB89bio, Inc. | COM | 9,316,333 | $67.7M | 2.2% | +2,838,084+43.8% | Added | History |
| NRIXNurix Therapeutics, Inc. | COM | 5,500,000 | $65.3M | 2.1% | +2,500,000+83.3% | Added | History |
| GERNGeron Corp | COM | 38,176,251 | $60.7M | 2.0% | +34,164,964+851.7% | Added | History |
| SRPTSarepta Therapeutics, Inc. | COM | 899,731 | $57.4M | 1.9% | +899,731 | New | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 1,350,000 | $48.9M | 1.6% | +696,487+106.6% | Added | History |
| ANIPAni Pharmaceuticals Inc | COM | 700,000 | $46.9M | 1.5% | +50,958+7.9% | Added | History |
| DNTHDianthus Therapeutics, Inc. | COM | 2,357,702 | $42.8M | 1.4% | +2,357,702 | New | History |
| IMCRImmunocore Holdings plc | ADS | 1,411,402 | $41.9M | 1.4% | +892,026+171.7% | Added | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 2,000,000 | $36.3M | 1.2% | +459,868+29.9% | Added | History |
| MAZEMaze Therapeutics, Inc. | COM | 3,269,126 | $36.0M | 1.2% | +3,269,126 | New | History |
| AMGNAmgen Inc | Stock | 113,035 | $35.2M | 1.1% | +113,035 | New | History |
| XENEXenon Pharmaceuticals Inc. | COM | 1,000,000 | $33.5M | 1.1% | +830,868+491.3% | Added | History |
| EWTXEdgewise Therapeutics, Inc. | COM | 1,400,000 | $30.8M | 1.0% | +689,579+97.1% | Added | History |
| MTSRMetsera, Inc. | COM | 1,094,408 | $29.8M | 1.0% | +1,094,408 | New | History |
| PCVXVaxcyte, Inc. | COM | 750,000 | $28.3M | 0.9% | +750,000 | New | History |
| AUTLAutolus Therapeutics plc | SPON ADS | 17,849,482 | $27.7M | 0.9% | +3,630,579+25.5% | Added | History |
| BCAXBicara Therapeutics Inc. | COM | 2,000,000 | $26.1M | 0.8% | 00.0% | Unchanged | History |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 8,859,648 | $25.3M | 0.8% | +8,859,648 | New | History |
| TECXTectonic Therapeutic, Inc. | COM | 1,401,938 | $24.8M | 0.8% | +1,401,938 | New | History |
| ABVXAbivax S.A. | SPONSORED ADS | 3,579,209 | $22.4M | 0.7% | 00.0% | Unchanged | History |
| MBXMBX Biosciences, Inc. | COM | 3,018,935 | $22.3M | 0.7% | 00.0% | Unchanged | History |
| GHRSGH Research PLC | ORDINARY SHARES | 2,000,000 | $22.1M | 0.7% | +2,000,000 | New | History |
| DYNDyne Therapeutics, Inc. | COM | 2,000,000 | $20.9M | 0.7% | 00.0% | Unchanged | History |
| ENGNenGene Therapeutics Inc. | COM | 4,557,575 | $20.4M | 0.7% | 00.0% | Unchanged | History |
| INSMINSMED Inc | COM PAR $.01 | 254,751 | $19.4M | 0.6% | +254,751 | New | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 741,068 | $18.6M | 0.6% | −39,710−5.1% | Reduced | History |
| SAGESage Therapeutics, Inc. | COM | 2,038,845 | $16.2M | 0.5% | +2,038,845 | New | History |
| TERNTerns Pharmaceuticals, Inc. | COM | 5,576,558 | $15.4M | 0.5% | 00.0% | Unchanged | History |
| KRROKorro Bio, Inc. | COM | 874,614 | $15.2M | 0.5% | 00.0% | Unchanged | History |
| ORKAOruka Therapeutics, Inc. | COM | 1,444,709 | $14.8M | 0.5% | +694,709+92.6% | Added | History |
| DFTXDefinium Therapeutics, Inc. | Stock | 2,500,000 | $14.6M | 0.5% | −316,594−11.2% | Reduced | History |
| UPBUpstream Bio, Inc. | COM | 2,299,567 | $14.1M | 0.5% | +1,299,567+130.0% | Added | History |
| OLMAOlema Pharmaceuticals, Inc. | COM | 3,442,833 | $12.9M | 0.4% | 00.0% | Unchanged | History |
| SEPNSepterna, Inc. | COM | 1,912,929 | $11.1M | 0.4% | 00.0% | Unchanged | History |
| NVAXNovavax Inc | COM NEW | 1,518,182 | $9.73M | 0.3% | −481,818−24.1% | Reduced | History |
| HELPCybin Inc. | COM NEW | 1,529,987 | $9.70M | 0.3% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 6,011,380 | $7.33M | 0.2% | 00.0% | Unchanged | History |
| PLRXPliant Therapeutics, Inc. | COM | 5,399,681 | $7.29M | 0.2% | −572,576−9.6% | Reduced | History |
| AVTXAvalo Therapeutics, Inc. | COM NEW | 859,876 | $6.89M | 0.2% | −7,124−0.8% | Reduced | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 767,016 | $6.51M | 0.2% | −509,065−39.9% | Reduced | History |
| BEAMBeam Therapeutics Inc. | COM | 315,765 | $6.17M | 0.2% | +315,765 | New | History |
| IVVDInvivyd, Inc. | COM | 9,722,254 | $5.88M | 0.2% | −967,349−9.0% | Reduced | History |
| XNCRXencor Inc | COM | 549,439 | $5.85M | 0.2% | +49,439+9.9% | Added | History |
| RGLSRegulus Therapeutics Inc. | COM | 3,262,564 | $5.71M | 0.2% | 00.0% | Unchanged | History |
| INOInovio Pharmaceuticals, Inc. | COM SHS | 3,119,162 | $5.08M | 0.2% | 00.0% | Unchanged | History |
| RAPPRapport Therapeutics, Inc. | COM | 457,556 | $4.59M | 0.1% | +457,556 | New | History |
| CNTXContext Therapeutics Inc. | COM | 7,419,355 | $4.54M | 0.1% | 00.0% | Unchanged | History |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 3,283,783 | $4.24M | 0.1% | 00.0% | Unchanged | History |
| ALGSAligos Therapeutics, Inc. | COM NEW | 444,110 | $3.66M | 0.1% | +200,000+81.9% | Added | History |
| SYRESpyre Therapeutics, Inc. | COM NEW | 219,015 | $3.53M | 0.1% | 00.0% | Unchanged | History |
| IMAImageneBio, Inc. | COM | 2,515,513 | $3.22M | 0.1% | +2,515,513 | New | History |
| OKUROnKure Therapeutics, Inc. | COM CL A | 523,989 | $2.25M | 0.1% | 00.0% | Unchanged | History |
| ALLKAllakos Inc. | COM | 7,232,701 | $1.65M | 0.1% | +1,528,419+26.8% | Added | History |
| NGNENeurogene Inc. | COM | 116,660 | $1.37M | <0.1% | +116,660 | New | History |
| CLYMClimb Bio, Inc. | COM | 1,040,115 | $1.27M | <0.1% | 00.0% | Unchanged | History |
Sold out since Q4 2024 (8)
Positions held at the end of Q4 2024 that are gone from this filing.
| Security | Class | Shares in Q4 2024 | Value in Q4 2024 | % of portfolio in Q4 2024 | History |
|---|---|---|---|---|---|
| SWTXSpringWorks Therapeutics, Inc. | COM | 3,460,756 | $125.0M | 4.7% | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 1,450,000 | $49.9M | 1.9% | History |
| NMRANeumora Therapeutics, Inc. | COM | 4,000,000 | $42.4M | 1.6% | History |
| GMABGenmab A/S | SPONSORED ADS | 2,000,000 | $41.7M | 1.6% | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 850,000 | $39.5M | 1.5% | History |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 1,350,000 | $22.6M | 0.8% | History |
| FDMT4D Molecular Therapeutics, Inc. | COM | 609,900 | $3.40M | 0.1% | History |
| NKTRNektar Therapeutics | COM | 1,975,998 | $1.84M | 0.1% | History |